Latest news
DAN Maintains Outperform Rating -- Price Target Raised to $37.00 - GuruFocusGuruFocus · Fri, 07 Aug 2026 22:12:34 GMTDD Maintains Outperform Rating -- Price Target Lowered to $176 b - GuruFocusGuruFocus · Fri, 07 Aug 2026 21:13:01 GMTMacquarie Adjusts PENN Entertainment PT to $25 From $23, Maintains Outperform Rating - MoomooMoomoo · Fri, 07 Aug 2026 20:05:50 GMTWedbush Adjusts PTon Xenon Pharmaceuticals to $71 From $63, Maintains Outperform Rating - MoomooMoomoo · Fri, 07 Aug 2026 20:05:42 GMTOppenheimer Adjusts PT on Maplebear to $65 From $60, Maintains Outperform Rating - MoomooMoomoo · Fri, 07 Aug 2026 18:09:50 GMTVOYA Maintains Outperform Rating -- Price Target Raised to $111. - GuruFocusGuruFocus · Fri, 07 Aug 2026 15:30:19 GMTNVMI Maintains Outperform Rating -- Price Target Lowered to $475 - GuruFocusGuruFocus · Fri, 07 Aug 2026 15:26:56 GMTOppenheimer Adjusts Sweetgreen PT to $8.50 From $10, Maintains Outperform Rating - MoomooMoomoo · Fri, 07 Aug 2026 14:57:51 GMT